|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.67 USD | -6.04% |
|
-2.42% | -36.12% |
| 05/08 | Ocular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says | MT |
| 31/07 | EyePoint Completes Enrollment in Phase 3 Diabetic Macular Edema Trials | MT |
| Market Cap | 978M 850M 792M 728M 1.38B 93.07B 1.39B 9.34B 3.65B 46.52B 3.67B 3.59B 154B | P/E 2026 * |
-3.27x | P/E 2027 * | -3.93x |
|---|---|---|---|---|---|
| Enterprise Value | 684M 594M 554M 509M 962M 65.07B 973M 6.53B 2.55B 32.53B 2.57B 2.51B 108B | EV / Sales 2026 * |
391x | EV / Sales 2027 * | 24.9x |
| Free-Float |
96.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: EyePoint, Inc.
| 1 day | -6.04% | ||
| 1 week | -2.42% | ||
| Current month | -4.73% | ||
| 1 month | -16.52% | ||
| 3 months | -15.74% | ||
| 6 months | -5.35% | ||
| Current year | -36.12% |
| 1 week | 11.54 |  | 13 |
| 1 month | 11.54 | | 14.99 |
| Current year | 11.3 | | 18.87 |
| 1 year | 9.51 | | 19.11 |
| 3 years | 3.91 | | 30.99 |
| 5 years | 2.19 | | 30.99 |
| 10 years | 2.19 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 67 | 10/07/2023 |
George Elston
DFI | Director of Finance/CFO | 61 | 14/11/2019 |
Ramiro Ribeiro
CTO | Chief Tech/Sci/R&D Officer | 43 | 04/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jay Duker
BRD | Director/Board Member | 67 | 10/07/2023 |
| Chairman | 77 | 10/09/2018 | |
John Landis
BRD | Director/Board Member | 73 | 25/10/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/7/26 | Fiscal year | Chief Executive Officer | 41,393 | 0.0494% | ||
| 30/6/26 | Fiscal year | Chief Technology Officer | 14,625 | 0.0174% | ||
| 23/3/26 | Others | Chief Executive Officer | 453,532 | 0.5478% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.04% | -2.42% | +16.00% | -9.53% | 978M | |
| -0.51% | -8.60% | +45.08% | +148.21% | 995B | |
| +0.20% | -4.42% | +49.05% | +50.81% | 614B | |
| -0.53% | -7.37% | +23.64% | +65.03% | 431B | |
| +0.70% | -0.44% | +40.99% | +35.96% | 353B | |
| -0.03% | -3.88% | +30.62% | +38.79% | 293B | |
| -0.64% | -11.54% | +3.55% | +6.72% | 245B | |
| -4.86% | -13.27% | -4.15% | -46.27% | 210B | |
| +2.94% | -0.78% | +29.17% | +60.32% | 210B | |
| +3.13% | +0.69% | +18.11% | +71.90% | 168B | |
| Average | -0.57% | -4.76% | +25.21% | +42.19% | 351.92B | |
| Weighted average by Cap. | +0.88% | -5.89% | +33.47% | +70.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.75M 1.52M 1.42M 1.3M 2.46M 167M 2.49M 16.72M 6.54M 83.29M 6.58M 6.43M 276M | 32.76M 28.44M 26.52M 24.36M 46.07M 3.12B 46.58M 313M 122M 1.56B 123M 120M 5.16B |
| Net income | -316M -275M -256M -235M -445M -30.07B -450M -3.02B -1.18B -15.03B -1.19B -1.16B -49.81B | -289M -251M -234M -215M -407M -27.51B -411M -2.76B -1.08B -13.75B -1.09B -1.06B -45.56B |
| Net Debt | -294M -256M -238M -219M -414M -28B -419M -2.81B -1.1B -14B -1.11B -1.08B -46.37B | -164M -142M -132M -122M -230M -15.56B -233M -1.56B -610M -7.78B -614M -601M -25.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | USD 11.67 | -6.04% | 2,929,693 |
| 03/08/26 | USD 12.42 | +1.39% | 1,479,461 |
| 31/07/26 | USD 12.25 | -4.74% | 1,711,475 |
| 30/07/26 | USD 12.86 | +7.89% | 1,561,104 |
| 29/07/26 | USD 11.92 | -0.33% | 2,054,155 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EYPT Stock
Select your edition
All financial news and data tailored to specific country editions
